Document Detail

Role of venoconstriction in thromboxane-induced pulmonary hypertension and edema in lambs.
MedLine Citation:
PMID:  2651387     Owner:  NLM     Status:  MEDLINE    
We evaluated the dose response to a stable thromboxane (Tx) A2 analogue (sTxA2; 0.3-30 micrograms) in the pulmonary circulation and its effect on the distribution of pressure gradients determined by the occlusion technique in isolated nonblood perfused newborn lamb lungs. The total pulmonary pressure gradient (delta Pt) was partitioned into pressure drops across the relatively indistensible arteries and veins (delta Pv) and relatively compliant vessels. We also evaluated the effects of prostacyclin (PGI2) and a Tx receptor antagonist (ONO 3708) on the sTxA2-induced pulmonary responses. Injection of sTxA2 caused a dose-related increase in the pulmonary arterial pressure, with the primary component of the increase in delta Pt (4.1 +/- 0.8 to 13.9 +/- 0.4 Torr) at 30 micrograms derived from the prominent rise in delta Pv (1.8 +/- 0.3 to 9.8 +/- 0.9 Torr). Infusion of PGI2 (0.4 reduced the response to sTxA2 mainly by attenuating the delta Pv elevation. Infusion of ONO 3708 (100 completely abolished the sTxA2-induced pulmonary hypertension. Injection of sTxA2 resulted in pulmonary edema characterized by a significant increase in wet-to-dry lung weight ratio (9.13 +/- 0.35 vs. 7.15 +/- 0.41 in control lungs). The sTxA2-induced pulmonary edema was increased by PGI2 and inhibited by ONO 3708. We conclude that thromboxane-induced pulmonary hypertension is primarily produced by venoconstriction and prostacyclin may worsen the edema induced by thromboxane.
K Yoshimura; M L Tod; K G Pier; L J Rubin
Related Documents :
16461017 - Association between slc11a1 polymorphisms and susceptibility to different clinical form...
840277 - Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.
1261327 - Bronchiectasis following heroin-induced pulmonary edema. rapid clearing of pulmonary in...
7186717 - Atypical radiological presentations of pulmonary tuberculosis.
8552517 - Adverse pacemaker hemodynamics evaluated by pulmonary venous flow monitoring.
22634977 - The vein collar: an anastomotic servant or a patency promoter? re-analysis of a randomi...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Journal of applied physiology (Bethesda, Md. : 1985)     Volume:  66     ISSN:  8750-7587     ISO Abbreviation:  J. Appl. Physiol.     Publication Date:  1989 Feb 
Date Detail:
Created Date:  1989-06-02     Completed Date:  1989-06-02     Revised Date:  2013-09-26    
Medline Journal Info:
Nlm Unique ID:  8502536     Medline TA:  J Appl Physiol (1985)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  929-35     Citation Subset:  IM    
Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Animals, Newborn
Blood Pressure / drug effects
Drug Synergism
Epoprostenol / pharmacology
Hypertension, Pulmonary / etiology*,  physiopathology
Pulmonary Edema / etiology*,  physiopathology
Thromboxane A2 / analogs & derivatives*,  pharmacology
Vascular Resistance / drug effects
Vasoconstriction / drug effects*
Reg. No./Substance:
35121-78-9/Epoprostenol; 57576-52-0/Thromboxane A2; 80408-46-4/STA 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Muscle glycogen storage postexercise: effect of mode of carbohydrate administration.
Next Document:  Effects of lung volume, volume history, and methacholine on lung tissue viscance.